Skip to main content

Actemra 162 mg/0.9 mL ACTPen® autoinjector Images

Generic Name: tocilizumab

This medication has been identified as Actemra 162 mg/0.9 mL ACTPen® autoinjector. It is supplied by Genentech, Inc.

Actemra is used in the treatment of Giant Cell Arteritis; Cytokine Release Syndrome; COVID-19; Juvenile Idiopathic Arthritis; Rheumatoid Arthritis and belongs to the drug class interleukin inhibitors. Risk cannot be ruled out during pregnancy. Actemra 162 mg/0.9 mL ACTPen® autoinjector is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Actemra 162 mg/0.9 mL ACTPen® autoinjector medicine

Actemra

Generic Name
tocilizumab
Strength
162 mg/0.9 mL ACTPen® autoinjector
Availability
Prescription only
Drug Class
Interleukin inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Genentech, Inc.
National Drug Code (NDC)
50242-0143

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.